Pure curcumin inhibits exogenous Wilms' tumor (WT1) (+/+) isoform protein via degradation pathway and protein kinase C in transfected U937 cells

Suwanna Semsri, Songyot Anuchapreeda, Nujeera Intasai, Tanyarat Jomgeow, Singkome Tima, Colleen A Sweeney, Pornngarm Limtrakul

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Wilms' tumor (WT1) gene overexpresses in leukemic cells which is alternatively spliced at two sites, yielding four isoforms: WT1 (+/+), (+/-), (-/+), and (-/-). Curcumin is one of major active components of the spice turmeric, widely known as anticancer. This study investigated the effects and inhibitory mechanism of pure curcumin on WT1 isoform-transfected U937 cells. WT1 transfected U937 cells were initially treated for 24 h, with 10 μM pure curcumin. Pure curcumin exhibited a strong inhibitory effect on WT1 (+/+) mRNA level detected by real time PCR. Treatment of WT1 transfected U937 cells with non-cytotoxic doses (10, 15, and 17 μM) of pure curcumin decreased WT1 protein levels in a dose dependent manner. Pure curcumin at the concentration of 15 μM significantly decreased the protein levels of the WT (+/+) isoform in a time-dependent manner. It also decreased exogenous WT1 (+/+) protein half-life. WT1 protein expression was inhibited by protein kinase C inhibitor (GF109203x) suggesting that pure curcumin decreased exogenous WT1 (+/+) expression in transfected U937 cells via protein kinase C during post-translational processing.

Original languageEnglish (US)
Pages (from-to)1846-1856
Number of pages11
JournalAfrican Journal of Pharmacy and Pharmacology
Volume5
Issue number16
DOIs
StatePublished - Oct 29 2011

Fingerprint

U937 Cells
Curcumin
Wilms Tumor
Protein Kinase C
Proteolysis
Protein Isoforms
Proteins
Wilms' Tumor Genes
Curcuma
Spices
Protein C Inhibitor
Protein Kinase Inhibitors
Half-Life
Real-Time Polymerase Chain Reaction
Messenger RNA

Keywords

  • Isoform
  • Protein kinase C
  • Pure curcumin
  • Transfected U937 cell line
  • Wilms' tumor (WT1)

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Pharmacology

Cite this

Pure curcumin inhibits exogenous Wilms' tumor (WT1) (+/+) isoform protein via degradation pathway and protein kinase C in transfected U937 cells. / Semsri, Suwanna; Anuchapreeda, Songyot; Intasai, Nujeera; Jomgeow, Tanyarat; Tima, Singkome; Sweeney, Colleen A; Limtrakul, Pornngarm.

In: African Journal of Pharmacy and Pharmacology, Vol. 5, No. 16, 29.10.2011, p. 1846-1856.

Research output: Contribution to journalArticle

Semsri, Suwanna ; Anuchapreeda, Songyot ; Intasai, Nujeera ; Jomgeow, Tanyarat ; Tima, Singkome ; Sweeney, Colleen A ; Limtrakul, Pornngarm. / Pure curcumin inhibits exogenous Wilms' tumor (WT1) (+/+) isoform protein via degradation pathway and protein kinase C in transfected U937 cells. In: African Journal of Pharmacy and Pharmacology. 2011 ; Vol. 5, No. 16. pp. 1846-1856.
@article{1ca103e7468c470e86789cac7e1278d0,
title = "Pure curcumin inhibits exogenous Wilms' tumor (WT1) (+/+) isoform protein via degradation pathway and protein kinase C in transfected U937 cells",
abstract = "Wilms' tumor (WT1) gene overexpresses in leukemic cells which is alternatively spliced at two sites, yielding four isoforms: WT1 (+/+), (+/-), (-/+), and (-/-). Curcumin is one of major active components of the spice turmeric, widely known as anticancer. This study investigated the effects and inhibitory mechanism of pure curcumin on WT1 isoform-transfected U937 cells. WT1 transfected U937 cells were initially treated for 24 h, with 10 μM pure curcumin. Pure curcumin exhibited a strong inhibitory effect on WT1 (+/+) mRNA level detected by real time PCR. Treatment of WT1 transfected U937 cells with non-cytotoxic doses (10, 15, and 17 μM) of pure curcumin decreased WT1 protein levels in a dose dependent manner. Pure curcumin at the concentration of 15 μM significantly decreased the protein levels of the WT (+/+) isoform in a time-dependent manner. It also decreased exogenous WT1 (+/+) protein half-life. WT1 protein expression was inhibited by protein kinase C inhibitor (GF109203x) suggesting that pure curcumin decreased exogenous WT1 (+/+) expression in transfected U937 cells via protein kinase C during post-translational processing.",
keywords = "Isoform, Protein kinase C, Pure curcumin, Transfected U937 cell line, Wilms' tumor (WT1)",
author = "Suwanna Semsri and Songyot Anuchapreeda and Nujeera Intasai and Tanyarat Jomgeow and Singkome Tima and Sweeney, {Colleen A} and Pornngarm Limtrakul",
year = "2011",
month = "10",
day = "29",
doi = "10.5897/AJPP11.149",
language = "English (US)",
volume = "5",
pages = "1846--1856",
journal = "African Journal of Pharmacy and Pharmacology",
issn = "1996-0816",
publisher = "Academic Journals",
number = "16",

}

TY - JOUR

T1 - Pure curcumin inhibits exogenous Wilms' tumor (WT1) (+/+) isoform protein via degradation pathway and protein kinase C in transfected U937 cells

AU - Semsri, Suwanna

AU - Anuchapreeda, Songyot

AU - Intasai, Nujeera

AU - Jomgeow, Tanyarat

AU - Tima, Singkome

AU - Sweeney, Colleen A

AU - Limtrakul, Pornngarm

PY - 2011/10/29

Y1 - 2011/10/29

N2 - Wilms' tumor (WT1) gene overexpresses in leukemic cells which is alternatively spliced at two sites, yielding four isoforms: WT1 (+/+), (+/-), (-/+), and (-/-). Curcumin is one of major active components of the spice turmeric, widely known as anticancer. This study investigated the effects and inhibitory mechanism of pure curcumin on WT1 isoform-transfected U937 cells. WT1 transfected U937 cells were initially treated for 24 h, with 10 μM pure curcumin. Pure curcumin exhibited a strong inhibitory effect on WT1 (+/+) mRNA level detected by real time PCR. Treatment of WT1 transfected U937 cells with non-cytotoxic doses (10, 15, and 17 μM) of pure curcumin decreased WT1 protein levels in a dose dependent manner. Pure curcumin at the concentration of 15 μM significantly decreased the protein levels of the WT (+/+) isoform in a time-dependent manner. It also decreased exogenous WT1 (+/+) protein half-life. WT1 protein expression was inhibited by protein kinase C inhibitor (GF109203x) suggesting that pure curcumin decreased exogenous WT1 (+/+) expression in transfected U937 cells via protein kinase C during post-translational processing.

AB - Wilms' tumor (WT1) gene overexpresses in leukemic cells which is alternatively spliced at two sites, yielding four isoforms: WT1 (+/+), (+/-), (-/+), and (-/-). Curcumin is one of major active components of the spice turmeric, widely known as anticancer. This study investigated the effects and inhibitory mechanism of pure curcumin on WT1 isoform-transfected U937 cells. WT1 transfected U937 cells were initially treated for 24 h, with 10 μM pure curcumin. Pure curcumin exhibited a strong inhibitory effect on WT1 (+/+) mRNA level detected by real time PCR. Treatment of WT1 transfected U937 cells with non-cytotoxic doses (10, 15, and 17 μM) of pure curcumin decreased WT1 protein levels in a dose dependent manner. Pure curcumin at the concentration of 15 μM significantly decreased the protein levels of the WT (+/+) isoform in a time-dependent manner. It also decreased exogenous WT1 (+/+) protein half-life. WT1 protein expression was inhibited by protein kinase C inhibitor (GF109203x) suggesting that pure curcumin decreased exogenous WT1 (+/+) expression in transfected U937 cells via protein kinase C during post-translational processing.

KW - Isoform

KW - Protein kinase C

KW - Pure curcumin

KW - Transfected U937 cell line

KW - Wilms' tumor (WT1)

UR - http://www.scopus.com/inward/record.url?scp=80655146486&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80655146486&partnerID=8YFLogxK

U2 - 10.5897/AJPP11.149

DO - 10.5897/AJPP11.149

M3 - Article

AN - SCOPUS:80655146486

VL - 5

SP - 1846

EP - 1856

JO - African Journal of Pharmacy and Pharmacology

JF - African Journal of Pharmacy and Pharmacology

SN - 1996-0816

IS - 16

ER -